This differential expression was probably due to extensive alterations in exon usage across the gene, whereas PDE4D displayed preferential expression of specific alternative transcript isoforms in CML CD34+CD38−ALDHhigh cells compared to their normal counterparts. This evidence concerns the gene PDE4D and chronic myelogenous leukemia, BCR-ABL1 positive.